Company Filing History:
Years Active: 2009
Title: Lin Xie: Innovator in Neurogenerative Research
Introduction
Lin Xie is a prominent inventor based in Novato, California. He has made significant contributions to the field of neurogenerative research, particularly in the context of ischemia. His work focuses on identifying factors that can enhance the migration and differentiation of stem cells into neurons.
Latest Patents
Lin Xie holds a patent for "Neurogenerative or neurotrophic factors for mitigating a symptom of ischemia." This invention pertains to the identification of neurogenerative and/or neurotrophic factors that can induce migration of stem cells to neural tissue and/or induce proliferation and/or differentiation of such cells into neurons. Such agents include, but are not limited to, stem cell factor (SCF), heparin binding EGF (HB-EGF), and VEGF.
Career Highlights
Lin Xie is affiliated with the Buck Institute for Age Research, where he conducts his innovative research. His work has the potential to significantly impact the treatment of ischemic conditions and improve patient outcomes.
Collaborations
Lin collaborates with notable colleagues, including David C. Greenberg and Kunlin Jin, who contribute to his research endeavors.
Conclusion
Lin Xie's contributions to neurogenerative research exemplify the importance of innovation in addressing complex medical challenges. His work continues to pave the way for advancements in the treatment of ischemia and related conditions.